ANN ARBOR, Mich., Jan. 15 /PRNewswire/ -- Tomball Regional Medical Center has selected the Clinical Xpert suite of products (formerly MercuryMD MData) from the Healthcare business of Thomson Reuters (http://www.thomsonreuters.com/business_units/healthcare/) to be a key component of its continuing effort to improve clinical performance and patient safety.
Tomball, a 358-bed facility in Tomball, Texas, will use Clinical Xpert Navigator (http://clinical.thomsonhealthcare.com/products/cxnavigator/) to deliver real-time patient data to physicians via their BlackBerry(R) smartphones, Palm(R) and Windows Mobile(R)-based mobile devices, and desktop computers. This ensures doctors have access to critical patient information at any time and from any location, improving efficiency and clinical decision-making.
The medical center will use Clinical Xpert CareFocus(TM) (http://clinical.thomsonhealthcare.com/products/CXCareFocus/) to monitor its patient data and identify high-risk patients - based on their laboratory results, vital signs, medications, diagnoses, age, gender, and other factors. When patients meet the hospital's preset "high-risk" criteria - suggesting, for example, that they are suffering from congestive heart failure or a dangerous drug interaction - Navigator is used to notify their clinician via desktop or mobile device. Early identification of these patients can prevent complications, save lives and shorten hospital stays.
"After a comprehensive review of the available options in the market, both for clinical surveillance and clinical mobility, we determined that Navigator and CareFocus from Thomson Reuters provided the most comprehensive solution - in terms of features, functionality and customer support - that met our strict criteria," said Keith Barber, chief operations officer and chief financial officer for Tomball Regional Medical Center. "These are both great solutions that will give our clinicians the tools they need to enhance decision-making at the point-of-care and improve efficiency."
John Butler, director of pharmacy at Tomball, said: "Using this clinical surveillance tool, CareFocus, to monitor our patient population and help identify the high-risk patients is a tremendous resource for our staff. It will enable us to respond quicker to these patients, saving time and money.
"And having immediate access to our patient's information on our PDAs means we can spend more time on rounds treating patients - and not combing through charts searching for the relevant clinical data."
Tomball will combine clinical solutions from Thomson Reuters to develop a closed-loop quality improvement process. The medical center also uses CareDiscovery(TM), a benchmarking solution from Thomson Reuters, to analyze clinical performance and make comparisons with peer-group and national benchmarks.
"Using CareFocus and CareDiscovery together gives us a powerful, end-to-end quality improvement solution that not only enables our clinicians to take direct and immediate action to treat at-risk patients but also allows us to monitor and measure our progress on an ongoing basis," said Bonnie Brown, Tomball's director of quality improvement. "This gives us a great opportunity to make tremendous strides toward raising the standard of care across our entire facility."
About Thomson Reuters
The Healthcare business of Thomson Reuters produces insights, information, benchmarks and analysis that enable organizations to manage costs, improve performance and enhance the quality of healthcare. Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. Thomson Reuters shares are listed on the New York Stock Exchange (NYSE: TRI); Toronto Stock Exchange (TSX: TRI); London Stock Exchange (LSE: TRIL); and Nasdaq (NASDAQ: TRIN). For more information, go to www.thomsonreuters.com.
About Tomball Regional Medical Center
Recognized for its full continuum of services and remarkable growth over the past 31 years, Tomball Regional Medical Center (TRMC) serves a population of 250,000 area residents. TRMC has been nationally recognized and was recently granted specialty accreditation for both Stroke Care and Cardiac Care. Through exceptional technology and a specialized medical staff, area residents receive a full range of medical services close to home. Services provided include open-heart surgery, neurosurgery, a new maternity floor and level III neonatal intensive care unit, inpatient rehabilitation, skilled nursing, psychiatric care, and home health care. The 150-acre campus also includes designated specialty centers: the Robert F. Schaper Heart Center, the Texas Wound and Lymphedema Center, the Texas Sports Medicine Center, a Cancer Treatment Center, and the Heritage Retirement Community. To learn more, visit www.tomballhospital.org, or call 281-401-7500.
|SOURCE Thomson Reuters|
Copyright©2009 PR Newswire.
All rights reserved